Denosumab linked to severe hypocalcemia in dialysis-dependent seniors
Jan 25, 2024
The risk increased for severe and very severe hypocalcemia for female dialysis-dependent Medicare patients aged 65 years or older.
Gabapentinoids linked to increased risk for severe exacerbation in COPD
Jan 16, 2024
Compared with matched nonusers, gabapentinoid users have an increased risk across indications of epilepsy, neuropathic pain and other chronic pain.
FDA finds no evidence linking Wegovy, Ozempic to suicidal behaviors
Jan 12, 2024
The agency, however, noted that officials cannot rule out that “a small risk may exist,” and said it will continue to investigate.
FDA allows Florida to import cheaper drugs from Canada
Jan 05, 2024
The plan would let Florida buy selected drugs in bulk from Canada, following FDA review.
New poll finds older Americans believe Medicare should cover weight-loss drugs
Dec 13, 2023
A 2003 law currently prohibits Medicare from covering medications specifically for weight loss. The poll was among those aged 50 to 80.
Statin use increased from 1999-2000 to 2013-2014, then plateaued
Dec 04, 2023
No change was seen in the proportion using statins from 2013-2014 to 2017-2018 for those with diabetes and with ASCVD risk greater than 20%.
Four JAK inhibitors have comparable efficacy, safety for RA
Dec 01, 2023
Baseline CRP, Clinical Disease Activity Index and glucocorticoid dose predict resistance to CDAI-low disease activity achievement.
Over-the-counter meds, exercise most prevalent treatment for chronic pain
Nov 20, 2023
The likelihood of using prescription opioids was higher for older persons, those with public insurance, and those with more severe pain, after adjustment for multiple factors.
AHA: Semaglutide cuts risk for CVD events in patients without diabetes
Nov 14, 2023
Findings seen over three years in adults with preexisting cardiovascular disease and overweight or obesity
Paxlovid not helpful for reducing most post-COVID-19 conditions
Oct 31, 2023
No differences were seen in most post-COVID-19 conditions examined individually or by organ system, apart from a lower combined risk for venous thromboembolism and pulmonary embolism.